凍結乾燥注射剤の世界市場レポート 2025年

凍結乾燥注射剤の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR3.9％で46億7,000万米ドルに成長します。予測期間の成長は、個別化医療の増加、生物製剤パイプラインの拡大、世界の健康への備え、希少疾病用医薬品の需要、患者のコンプライアンス重視の高まりに起因すると考えられます。予測期間における主な動向には、凍結乾燥併用療法の革新、凍結乾燥ワクチンの拡大、QBD（Quality-by-Design）原則の統合、救急医療における凍結乾燥薬の利用、凍結乾燥プロセスのバリデーションに対する規制の重視などがあります。

心臓疾患の罹患率の増加が、今後の凍結乾燥注射剤市場の成長を牽引すると予測されます。心臓疾患には、弁、心室、血管、電気システム、全体的なポンプ能力の問題など、心臓の構造や機能に影響を及ぼす幅広い疾患が含まれます。血栓溶解薬、抗不整脈薬、強心薬、降圧薬などの凍結乾燥注射剤は、その安定性、利便性、柔軟性、迅速な再構成、改善された生物学的利用能、および汚染のリスクの低減により、様々な心臓疾患の治療に利用されています。例えば、英国を拠点とする心臓血管研究の慈善団体であるBritish Heart Foundationが発表したデータによると、英国では約760万人が心臓・循環器疾患に罹患しており、その内訳は男性約400万人、女性約360万人です。これらの疾患は、英国における全死亡者の約27％を占め、年間17万人以上、毎日約480人、つまり3分に1人が死亡していることになります。したがって、心臓疾患の発生率の上昇は、予測期間中の凍結乾燥注射剤市場成長の重要な促進要因です。

製薬業界における需要の増加は、今後数年間の凍結乾燥注射剤市場の成長を促進すると予測されています。製薬業界におけるこのような成長の背景には、継続的な研究開発の革新、規制当局による承認の成功、高齢化、技術の進歩、世界化、ヘルスケアへのアクセスの改善などがあります。製薬産業が拡大するにつれ、安定的で長持ちする製剤へのニーズが高まっています。例えば、2023年2月、米国の製薬会社Merck &Co.Inc.の2022年の世界売上高は593億米ドルで、前年比22%増となった。したがって、製薬業界における需要の高まりは、凍結乾燥注射剤市場の成長を促進する重要な要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界凍結乾燥注射剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の凍結乾燥注射剤市場：成長率分析
• 世界の凍結乾燥注射剤市場の実績：規模と成長, 2019-2024
• 世界の凍結乾燥注射剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界凍結乾燥注射剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の凍結乾燥注射剤市場：パッケージングタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 特殊包装
• ポイントオブケア再構成
• 使い捨てバイアル
• その他の梱包タイプ
• 世界の凍結乾燥注射剤市場配送タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• シングルステップデバイス
• マルチステップデバイス
• 充填済み希釈液シリンジ
• 独自の再構成デバイス
• 世界の凍結乾燥注射剤市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症
• 自己免疫疾患
• 代謝状態
• その他の適応症
• 世界の凍結乾燥注射剤市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター（ASC）
• 専門クリニック
• その他のエンドユーザー
• 世界の凍結乾燥注射剤市場、特殊包装のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• デュアルチャンバーシステム
• プレフィルドシリンジ
• 世界の凍結乾燥注射剤市場、ポイントオブケア再構成のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポータブル再構成デバイス
• すぐに使えるキット
• 世界の凍結乾燥注射剤市場、使い捨てバイアルの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ガラスバイアル
• プラスチックバイアル
• 世界の凍結乾燥注射剤市場、その他の包装タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• マルチドーズバイアル
• ブリスターパック
• バルク包装ソリューション

第7章 地域別・国別分析

• 世界の凍結乾燥注射剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の凍結乾燥注射剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 凍結乾燥注射剤市場：競合情勢
• 凍結乾燥注射剤市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Becton Dickinson and Company
• Baxter International Inc.
• Sandoz
• Nipro Corporation
• B. Braun SE
• Aurobindo Pharmaceuticals
• Schott AG
• Zydus Lifesciences
• Recipharm AB
• Vetter Pharma-Fertigung GmbH & Co. KG
• Fresenius Kabi USA LLC
• Vetter Pharma-Fertigung GmbH & Co. KG
• CordenPharma International
• Aristopharma Limited.
• Accord Healthcare

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 凍結乾燥注射剤市場2029：新たな機会を提供する国
• 凍結乾燥注射剤市場2029：新たな機会を提供するセグメント
• 凍結乾燥注射剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Lyophilized injectable drugs, commonly known as freeze-dried drugs, undergo a process called lyophilization to remove water from the medications. This technique involves freezing the drugs and then subjecting them to a vacuum, causing the frozen water to transition directly from a solid to a gas state. Lyophilized injectable drugs offer improvements in bioavailability, stability, solubility, and patient compliance.

These drugs are packaged in various types, including specialty packaging, point-of-care reconstitution, single-use vials, and others. Point-of-care reconstitution involves preparing medication for immediate use by reconstituting a lyophilized drug at the point of administration or patient bedside. Different delivery methods include single-step devices, multi-step devices, prefilled diluent syringes, and proprietary reconstitution devices. These devices are utilized in the treatment of various conditions such as infectious diseases, autoimmune diseases, and metabolic conditions. The end-users of lyophilized injectable drugs encompass hospitals, ambulatory surgery centers (ASCs), specialty clinics, and other healthcare facilities.

The lyophilized injectable drugs market research report is one of a series of new reports from The Business Research Company that provides lyophilized injectable drugs market statistics, including lyophilized injectable drugs industry global market size, regional shares, competitors with a lyophilized injectable drugs market share, detailed lyophilized injectable drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the lyophilized injectable drugs industry. This lyophilized injectable drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lyophilized injectable drugs market size has grown steadily in recent years. It will grow from $3.89 billion in 2024 to $4.01 billion in 2025 at a compound annual growth rate (CAGR) of 3.1%. The growth in the historic period can be attributed to the rise in chronic diseases, the growing biopharmaceutical industry, expanding geriatric population, clinical advancements and trials, globalization of pharmaceutical manufacturing

The lyophilized injectable drugs market size is expected to see steady growth in the next few years. It will grow to $4.67 billion in 2029 at a compound annual growth rate (CAGR) of 3.9%. The growth in the forecast period can be attributed to rise in personalized medicine, expansion of biologics pipeline, global health preparedness, demand for orphan drugs, increased focus on patient compliance. Major trends in the forecast period include innovations in lyophilized combination therapies, expansion of lyophilized vaccines, integration of quality-by-design (QBD) principles, utilization of lyophilized drugs in emergency medicine, regulatory emphasis on lyophilization process validation.

The increasing incidence of cardiac disorders is projected to drive the growth of the lyophilized injectable drugs market in the future. Cardiac disorders encompass a wide range of conditions affecting the heart's structure and function, including issues with the valves, chambers, blood vessels, electrical system, and overall pumping ability. Lyophilized injectable drugs, such as thrombolytic agents, antiarrhythmic medications, inotropic agents, and antihypertensive medications, are utilized in treating various cardiac disorders due to their stability, convenience, flexibility, rapid reconstitution, improved bioavailability, and reduced risk of contamination. For example, data published by the British Heart Foundation, a UK-based cardiovascular research charity, revealed that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, including around 4 million males and 3.6 million females. These conditions account for about 27% of all deaths in the UK, resulting in over 170,000 fatalities annually, or roughly 480 deaths each day-equating to one death every three minutes. Therefore, the rising incidence of cardiac disorders is a significant driver for the growth of the lyophilized injectable drugs market during the forecast period.

The increasing demand within pharmaceutical industries is anticipated to drive the growth of the lyophilized injectable drugs market in the coming years. This growth in the pharmaceutical sector can be attributed to ongoing R&D innovations, successful regulatory approvals, an aging population, technological advancements, globalization, and improved access to healthcare. As the pharmaceutical industry expands, the need for stable, long-lasting drug formulations rises. For example, in February 2023, Merck & Co. Inc., a US-based pharmaceutical company, reported global sales of $59.3 billion for 2022, marking a 22% increase compared to the previous year. Therefore, the rising demand in pharmaceutical industries is a key factor fueling the growth of the lyophilized injectable drugs market.

The escalating incidence of cardiovascular diseases is poised to propel the lyophilized injectable drugs market. Cardiovascular diseases encompass a spectrum of conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and heart valve problems. Lyophilized injectable drugs address cardiovascular diseases by providing stable and durable formulations that enhance drug efficacy, ensure precise dosing, and enable convenient administration. This contributes to improved patient outcomes and treatment compliance. In 2022, according to data from the Centers for Disease Control and Prevention (CDC), heart disease accounted for over 659,000 deaths in the United States, representing one in every four fatalities. Specifically, coronary heart disease, the most prevalent type, claimed 375,476 lives in 2021. Therefore, the escalating cases of cardiovascular diseases are expected to drive the lyophilized injectable drugs market forward.

The prevailing trend in the lyophilized injectable drug market is the emphasis on product innovations, with major companies actively pursuing novel drug delivery systems to enhance their market profitability. Notably, in June 2022, Gufic Biosciences Ltd., an India-based pharmaceutical company, introduced Dual Chamber Bags (DCB), a critical innovation for reconstituting lyophilized injectable drugs. These bags offer multiple advantages, including a reduction in the risk of bloodstream infections, ensuring patient safety, and preventing prescription errors.

Leading companies in the lyophilized injectable drug market are channeling their efforts into leveraging innovative technologies, such as non-invasive technology, for the development of lyophilized injectable drugs. Non-invasive technology involves methods or devices that gather information or perform tasks without penetrating the skin or entering bodily orifices. For example, in October 2023, COMSER Pharma, a Spain-based provider of compliance services and freeze-dry pharmaceutical solutions, introduced LyoFlow, an innovative technology for lyophilized injectable drug production. LyoFlow is a disruptive solution enabling real-time, non-invasive extraction of the mass flow in a freeze-drying process, easily integratable into any lyophilization equipment, and facilitating continuous monitoring of product quality throughout the process.

In April 2022, Recipharm AB, a pharmaceutical contract development and manufacturing organization based in Sweden, acquired Vibalogics for an undisclosed amount. This acquisition aims to reinforce the company's position in the biologics market, with a specific focus on manufacturing drug ingredients for novel advanced therapeutic medicinal goods. Vibalogics, a Germany-based manufacturing company, specializes in the production of sophisticated live biological products, operating within the lyophilized injectable drugs market.

Major companies operating in the lyophilized injectable drugs market include Pfizer Inc., Hoffmann-La Roche Ltd, Merck & Co Inc., Sanofi SA, Novo Nordisk A/S, Becton Dickinson and Company, Baxter International Inc., Sandoz, Nipro Corporation, B. Braun SE, Aurobindo Pharmaceuticals, Schott AG, Zydus Lifesciences, Recipharm AB, Vetter Pharma-Fertigung GmbH & Co. KG, Fresenius Kabi USA LLC, Vetter Pharma-Fertigung GmbH & Co. KG, CordenPharma International, Aristopharma Limited., Accord Healthcare, Jubilant HollisterStier LLC, Ciron Drugs & Pharmaceuticals Pvt Ltd., MSN Laboratories, Qilu pharmaceutical Co Ltd., Genex Pharma

North America was the largest region in the lyophilized injectable drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyophilized injectable drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lyophilized injectable drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lyophilized injectable drugs market consists of revenue by entities by providing Pre-freezing, primary drying, and secondary drying. The market value includes the value of related goods sold by the service provider or included within the service offering. The lyophilized injectable drugs market also includes sales of ceftriaxone, vancomycin, and meropenem. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lyophilized Injectable Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lyophilized injectable drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lyophilized injectable drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lyophilized injectable drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Packaging Type: Specialty Packaging, Point-Of-Care Reconstitution, Single-Use Vials, Other Packaging Types.
• 2) By Type of Delivery: Single-Step Devices, Multi-Step Devices, Prefilled Diluent Syringes, Proprietary Reconstitution Devices.
• 3) By Indication: Infectious Diseases, Autoimmune Diseases, Metabolic Conditions, Other Indications.
• 4) By End-User: Hospitals, Ambulatory Surgery Centers (ASCs), Specialty Clinics, Other End-Users.
• Subsegments:
• 1) By Specialty Packaging: Dual-Chamber Systems; Prefilled Syringes
• 2) By Point-Of-Care Reconstitution: Portable Reconstitution Devices; Ready-To-Use Kits
• 3) By Single-Use Vials: Glass Vials; Plastic Vials
• 4) By Other Packaging Types: Multi-Dose Vials; Blister Packs; Bulk Packaging Solutions
• Companies Mentioned: Pfizer Inc.; Hoffmann-La Roche Ltd; Merck & Co Inc.; Sanofi SA; Novo Nordisk A/S
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lyophilized Injectable Drugs Market Characteristics

3. Lyophilized Injectable Drugs Market Trends And Strategies

4. Lyophilized Injectable Drugs Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Lyophilized Injectable Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Lyophilized Injectable Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Lyophilized Injectable Drugs Market Growth Rate Analysis
• 5.4. Global Lyophilized Injectable Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Lyophilized Injectable Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Lyophilized Injectable Drugs Total Addressable Market (TAM)

6. Lyophilized Injectable Drugs Market Segmentation

• 6.1. Global Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Specialty Packaging
• Point-Of-Care Reconstitution
• Single-Use Vials
• Other Packaging Types
• 6.2. Global Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Step Devices
• Multi-Step Devices
• Prefilled Diluent Syringes
• Proprietary Reconstitution Devices
• 6.3. Global Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Diseases
• Autoimmune Diseases
• Metabolic Conditions
• Other Indications
• 6.4. Global Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgery Centers (ASCs)
• Specialty Clinics
• Other End-Users
• 6.5. Global Lyophilized Injectable Drugs Market, Sub-Segmentation Of Specialty Packaging, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dual-Chamber Systems
• Prefilled Syringes
• 6.6. Global Lyophilized Injectable Drugs Market, Sub-Segmentation Of Point-Of-Care Reconstitution, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Portable Reconstitution Devices
• Ready-To-Use Kits
• 6.7. Global Lyophilized Injectable Drugs Market, Sub-Segmentation Of Single-Use Vials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glass Vials
• Plastic Vials
• 6.8. Global Lyophilized Injectable Drugs Market, Sub-Segmentation Of Other Packaging Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Multi-Dose Vials
• Blister Packs
• Bulk Packaging Solutions

7. Lyophilized Injectable Drugs Market Regional And Country Analysis

• 7.1. Global Lyophilized Injectable Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Lyophilized Injectable Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lyophilized Injectable Drugs Market

• 8.1. Asia-Pacific Lyophilized Injectable Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lyophilized Injectable Drugs Market

• 9.1. China Lyophilized Injectable Drugs Market Overview
• 9.2. China Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lyophilized Injectable Drugs Market

• 10.1. India Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lyophilized Injectable Drugs Market

• 11.1. Japan Lyophilized Injectable Drugs Market Overview
• 11.2. Japan Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lyophilized Injectable Drugs Market

• 12.1. Australia Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lyophilized Injectable Drugs Market

• 13.1. Indonesia Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lyophilized Injectable Drugs Market

• 14.1. South Korea Lyophilized Injectable Drugs Market Overview
• 14.2. South Korea Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lyophilized Injectable Drugs Market

• 15.1. Western Europe Lyophilized Injectable Drugs Market Overview
• 15.2. Western Europe Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lyophilized Injectable Drugs Market

• 16.1. UK Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lyophilized Injectable Drugs Market

• 17.1. Germany Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lyophilized Injectable Drugs Market

• 18.1. France Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lyophilized Injectable Drugs Market

• 19.1. Italy Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lyophilized Injectable Drugs Market

• 20.1. Spain Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lyophilized Injectable Drugs Market

• 21.1. Eastern Europe Lyophilized Injectable Drugs Market Overview
• 21.2. Eastern Europe Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lyophilized Injectable Drugs Market

• 22.1. Russia Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lyophilized Injectable Drugs Market

• 23.1. North America Lyophilized Injectable Drugs Market Overview
• 23.2. North America Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lyophilized Injectable Drugs Market

• 24.1. USA Lyophilized Injectable Drugs Market Overview
• 24.2. USA Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lyophilized Injectable Drugs Market

• 25.1. Canada Lyophilized Injectable Drugs Market Overview
• 25.2. Canada Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lyophilized Injectable Drugs Market

• 26.1. South America Lyophilized Injectable Drugs Market Overview
• 26.2. South America Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lyophilized Injectable Drugs Market

• 27.1. Brazil Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lyophilized Injectable Drugs Market

• 28.1. Middle East Lyophilized Injectable Drugs Market Overview
• 28.2. Middle East Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lyophilized Injectable Drugs Market

• 29.1. Africa Lyophilized Injectable Drugs Market Overview
• 29.2. Africa Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lyophilized Injectable Drugs Market Competitive Landscape And Company Profiles

• 30.1. Lyophilized Injectable Drugs Market Competitive Landscape
• 30.2. Lyophilized Injectable Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

31. Lyophilized Injectable Drugs Market Other Major And Innovative Companies

• 31.1. Becton Dickinson and Company
• 31.2. Baxter International Inc.
• 31.3. Sandoz
• 31.4. Nipro Corporation
• 31.5. B. Braun SE
• 31.6. Aurobindo Pharmaceuticals
• 31.7. Schott AG
• 31.8. Zydus Lifesciences
• 31.9. Recipharm AB
• 31.10. Vetter Pharma-Fertigung GmbH & Co. KG
• 31.11. Fresenius Kabi USA LLC
• 31.12. Vetter Pharma-Fertigung GmbH & Co. KG
• 31.13. CordenPharma International
• 31.14. Aristopharma Limited.
• 31.15. Accord Healthcare

32. Global Lyophilized Injectable Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lyophilized Injectable Drugs Market

34. Recent Developments In The Lyophilized Injectable Drugs Market

35. Lyophilized Injectable Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Lyophilized Injectable Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Lyophilized Injectable Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Lyophilized Injectable Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer